Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Pediatric Health Care: An Introduction

Author(s):  Williams LaVonn A

Issue:  Jan/Feb 2013 - Volume 17, Number 1
View All Articles in Issue

Page(s):  6-8

Pediatric Health Care: An Introduction Page 1
Pediatric Health Care: An Introduction Page 2
Pediatric Health Care: An Introduction Page 3

Download in electronic PDF format for $65

Abstract:  Pediatric healthcare, to include compounded medications, is achallenge for healthcare providers. Although current studies have provided important new informationabout drug safety and effectiveness for children, carrying outstudies in children is difficult. Age-appropriate equipment and medical techniques, along with specialists who are sensitive to a child’s concerns, are a must. Therefore, experts must build a foundationand resources that are needed to conduct studies involving pediatric patients. Compounding pharmacists welcome reliable data from which to use when compounding medications for such an elite group of patients.

Related Keywords: LaVonn A. Williams, children, child, infants, drug safety, dosages, off-label medication use, loratidine, fentanyl, fluvoxamine maleate, midazolam hydrochloride, gabapentin, famotidine, sevoflurane, United States Food and Drug Administration, FDA

Related Categories: LEGAL, PEDIATRICS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Veterinary Transdermal Medications: A to Z
Davidson Gigi S
Mar/Apr 2003
Pg. 106-113

Pediatric Health Care: An Introduction
Williams LaVonn A
Jan/Feb 2013
Pg. 6-8

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
Jul/Aug 2016
Pg. 351

View Sample
Pediatric Compounding: Coloring Outside the Lines
Preckshot John
Jan/Feb 2001
Pg. 6-8

U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Miller David G
Jul/Aug 2015
Pg. 303-305

The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone
Brunner Scott
Jan/Feb 2023
Pg. 22-23

Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Martin Matt
Sep/Oct 2018
Pg. 401-404

The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States
Stephenson Kenna
, Jones William, Stephenson Douglas M M
May/Jun 2006
Pg. 175-183

Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance
Greeson Nicole MH
, Mixon William, Allan W Chris
Sep/Oct 2020
Pg. 371-379